There was no association between the risk of prostate cancer and IGF-2 (OR=0.72; 95% CI: 0.36–1.44; Table 3) or IGFBP-3 levels (OR=1.05; 95%CI: 0.82–1.35; Table 3). Here, IGFBP3 is linked to prostate cancer.